With the continuing COVID-19 pandemic, several researchers have brought out candidate vaccines, some of which have undergone human testing. However, it is unclear whether they are genuinely protective ...

Advantages of Utilizing a Light-Scattering Toolbox in Vaccine Development Virus-like particles (VLPs) are biomolecular nanoparticles formed by controlled self-assembly of viral structural proteins.

Nanomedicine. 2014;9(12):1857-1868. Virus-like particles (VLPs) are self assembled protein structures often containing hollow interiors. VLPs can be produced heterologously through different hosts ...

In a recent study posted to the bioRxiv* preprint server, researchers proposed an optimal system to generate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus-like particles (VLPs) ...

Virus-like particles (VLPs) are protein-based structures that mimic viruses and bind to antibodies. Because VLPs aren't infectious, they show promise as vaccine platforms for many viral diseases, ...

University of Leeds researchers have taken a major step towards producing a more affordable and lower-risk polio vaccine using virus-like particles (VLPs). These particles mimic the outer protein ...

Virus-like particles (VLPs), mere shells of actual viruses, can be used to create vaccines in weeks instead of months, according to Novavax Inc. of Rockville, Md. The research could make vaccine ...

Virus-Like Particles (VLPs) are self-assembling protein structures that mimic the architecture and surface features of viruses without containing genetic material. These non-infectious particles are ...

Nanomedicine. 2014;9(12):1857-1868. A major area of interest in the field of vaccine development for lung-associated pathogens like influenza is new vaccine strategies that will provide broad serotype ...